Geneticallyengineered mouse models (GEMMs) have been extensively used to gain mechanisticinsights into the biology of KRAS-mutant lung cancer and to assess the efficacy ofnovel therapeutics. The gene discussed is KRAS; the disease is lung carcinoma.